Galectin Therapeutic (GALT)

$2.17 0.11 (5.34%)

16:00 EDT GALT Stock Quote Delayed 30 Minutes

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

By William White, InvestorPlace Writer Jul 6, 2022

We're starting off Wednesday with a breakdown of the biggest pre-market stock movers for investors to keep an eye on today!

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

GALT Stock: The Big Trial News That Has Galectin Therapeutics Soaring

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Friday Morning

More Articles

Volume:

Previous Close -

Market Cap 128.89M

PE Ratio -6.58

EPS -0.33

Volume (Avg. Vol.) 102,967

Day's Range $2.05 - $2.20

52-Week Range $1.02 - $2.57

Dividend & Yield N/A (N/A)

GALT Stock Predictions, Articles, and Galectin Therapeutic News

From InvestorPlace
From the Web

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning

By William White, InvestorPlace Writer Apr 14, 2021

We're at the midpoint of the week and InvestorPlace.com is taking a look at the biggest pre-market movers for investors to keep an eye on.

Today’s Biggest Pre-Market Movers: 10 Top Gainers and Losers on Wednesday Morning

By William White, InvestorPlace Writer Apr 7, 2021

We're only halfway through the week but there's plenty of pre-market movers that investors will want to keep an eye on today.

5 Biotech Stocks to Play the Sector’s Next Big Trend: NASH

By Aaron Levitt, InvestorPlace Contributor Sep 26, 2018

Looking for blockbuster potential? These five biotech stocks may have found it in treating NASH -- an untapped market of up to $35 billion.

5 Clinical-Stage Biotech Stocks to Buy Under $10

By Aaron Levitt, InvestorPlace Contributor May 29, 2018

Clinical-stage biotech stocks offer plenty of promise to investors looking to take on some risk. Here are five to buy today.

25 Biotechnology Stocks to Buy Now

By Portfolio Grader Oct 3, 2016

25 Biotechnology stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an "A" ("strong buy") or "B" overall ("buy").

Hottest Manufacturing Stocks Now – ARRY CHMT SMMT SELB

By Portfolio Grader Sep 26, 2016

The following stocks were moving the Manufacturing sector today.

Biggest Movers in Manufacturing Stocks Now – GALT CERC OVAS EBIO

By Portfolio Grader Sep 21, 2016

The Manufacturing sector saw plenty of trading activity today, including the following leaders and losers.

13 Biotechnology Stocks to Sell Now

By Portfolio Grader Jul 18, 2016

The ratings of 13 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

29 Biotechnology Stocks to Sell Now

By Portfolio Grader Jun 27, 2016

This week, the overall grades of 29 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

28 Biotechnology Stocks to Sell Now

By Portfolio Grader Jun 20, 2016

This week, the overall grades of 28 Biotechnology stocks are lower, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

27 Biotechnology Stocks to Sell Now

By Portfolio Grader May 16, 2016

The ratings of 27 Biotechnology stocks are down this week, according to the Portfolio Grader database. Each of these rates a "D" ("sell") or "F" overall ("strong sell").

Biotech Stocks With Upside Target Ebola, Liver Disease

By The Life Sciences Report, Streetwise Reports Sep 16, 2014

Developing successful Ebola and liver disease treatments is an incredibly risky opportunity for biotech stocks to create value.

H.C. Wainwright Sticks to Their Buy Rating for Galectin Therapeutics (GALT)

From TipRanks Dec 2, 2022

In a report released today, Ed Arce from H.C. Wainwright maintained a Buy rating on Galectin Therapeutics (GALT – Research Report), with a price ta...

Analysts Are Bullish on Top Healthcare Stocks: Galectin Therapeutics (GALT), Viridian Therapeutics (VRDN)

From TipRanks Nov 15, 2022

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Galectin Therapeutics (

H.C. Wainwright Sticks to Its Buy Rating for Galectin Therapeutics (GALT)

From TipRanks Oct 11, 2022

In a report released on October 7, Ed Arce from H.C. Wainwright maintained a Buy rating on Galectin Therapeutics (GALT – Research Report), with a price target...

Galectin Therapeutics (GALT) Gets a Buy from H.C. Wainwright

From TipRanks Aug 16, 2022

H.C. Wainwright analyst Ed Arce maintained a Buy rating on Galectin Therapeutics (GALT – Research Report) today and set a price target of $11.00. The company&...

Analysts’ Top Healthcare Picks: Galectin Therapeutics (GALT), Clearside Biomedical (CLSD)

From TipRanks Jul 26, 2022

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Galectin Therapeutics (

Recap: Galectin Therapeutics Q1 Earnings

From Benzinga May 16, 2022

Galectin Therapeutics (NASDAQ:GALT) reported its Q1 earnings results on Monday, May 16, 2022 at 08:00 AM. Here's what investors need to know about the announcement.